Objectives: Critical hand ischemia caused by below-the-elbow atherosclerotic occlusive disease is increasing. The aim of this study was to examine the patient-centered outcomes of open and endovascular interventions in patients presenting with critical ischemia.
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Distal Vein Patch Use and Limb Events Following Infragenicular Prosthetic Bypasses
Bernardino Castelo Branco, Panos Kougias, Jonathan D. Braun, Joseph L. Mills Sr, Neal R. Barshes. Baylor College of Medicine, Houston, Tex
Objectives: In the absence of suitable autologous vein, prosthetic grafts are commonly used as alternate conduits for infragenicular bypasses. The primary purpose of this study was to investigate whether use of vein patch adjuncts decreased the incidence of subsequent major adverse limb events (MALEs).
Methods: All patients undergoing infragenicular prosthetic bypass grafts between January 2009 and July 2016 were retrospectively reviewed. Patient demographics, clinical data, and outcomes (MALE and graft patency) were collected. Patients were compared according to treatment group (patch vs no patch). Kaplan-Meier curves were used to analyze follow-up results.
Results: Over the study period, 373 patients underwent infragenicular bypass at our institution. Of those, 93 (24.9%) had prosthetic grafts: 39 with patch and 54 without patch. Overall, 92 patients (98.9%) were male, with a mean age of 63 years. Age and the rates of comorbidities, such as hypertension, chronic obstructive pulmonary disease, diabetes mellitus, and end-stage renal disease, did not differ between the two groups. Median follow-up time was 7.8 months (range, 1-89 months). Reintervention rates were significantly higher in the no patch group (50% vs 31%; odds ratio, 2.3; 95% confidence interval, 1.1-10.7; P ¼ .04). When occluded, patients in the no patch group more often presented with acute limb ischemia (43% vs 30%; odds ratio, 1.4; 95% confidence interval, 0.7-3.1; P ¼ .34). Kaplan-Meier curves demonstrated an improved freedom from MALE in the vein patch group that did not reach significance (log-rank P ¼ .269; Fig) . The higher primary patency in the vein patch group did not reach significance (46% vs 35%; P ¼ .206).
Conclusions: Use of a distal vein patch demonstrates significantly reduced reintervention rates and a somewhat decreased incidence of acute limb ischemia. This may represent a benefit beyond a previouslydemonstrated improvement in patency.
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Defining Predictors of Ambulation and Functional Outcome After Major Lower Extremity Amputation: A Contemporary Review
Atish Chopra, Enjae Jung, Cherrie Abraham, Timothy Liem, Gregory Landry, Gregory Moneta, Erica Mitchell. Oregon Health & Science University, Portland, Ore Objectives: Major lower extremity amputations (MLEA) are on the rise despite increased attention placed on prevention. It is unknown whether postamputation functional outcomes, ambulation, and the ability to predict these outcomes have changed with an increasingly aging and obese patient population. Accordingly, we sought to evaluate contemporary trends.
Methods: A retrospective record review was performed to identify patients undergoing MLEA using Current Procedural Terminology codes in a university hospital. Demographics, comorbidities, perioperative variables, and outcomes were obtained. Descriptive statistics, t-tests, c 2 , and multivariate logistic regression modeling were used where appropriate. Survival analyses were performed with the Kaplan-Meier method.
Results: From October 2005-November 2016, 206 patients (147 male; mean age, 62 6 13.5 years) underwent 307 MLEAs (90.2% below-knee [BKA], 1.3% through-knee [TKA], 8.5% above-knee amputations [AKA]) related to critical limb ischemia or infection. Diabetes was prevalent in 47.1%, end-stage renal disease in 10.2%, and coronary artery disease in 34% patients. Thirty-day operative mortality was 1.5%. Mean follow-up was 178.8 6 266.92 days. Conversion from BKA to AKA was 2.9%. Estimated survival was 86% at 1 year and 78% at 3 years. The overall postamputation ambulatory rate was 48.7% at the last follow-up. Nonambulatory patients had a higher basal metabolic index ([BMI] ; 30.9 6 8.0 vs 25.62 6 5.43; P < .001), dementia (12.3% vs 0%; P < .001), chronic alcohol use (9% vs 1.1%; P ¼ .01), chronic intravenous drug use 
